Bupropion differentially impacts acquisition of methamphetamine self-administration and sucrose-maintained behavior

Pharmacology Biochemistry and Behavior

Volumn 89, Issue 3, 2008, Pages 463-472

  Reichel, Carmela M ^a   Linkugel, Jessica D ^a   Bevins, Rick A ^a  

^a UNIVERSITY OF NEBRASKA LINCOLN   (United States)

Author keywords

Appetitive reinforcers; Conditioning; Drug taking; Prevention; Wellbutrin; Zyban

Indexed keywords

AMFEBUTAMONE; METHAMPHETAMINE;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIORAL SCIENCE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG SELF ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REINFORCEMENT;

AMPHETAMINE-RELATED DISORDERS; ANIMALS; BUPROPION; MALE; METHAMPHETAMINE; RATS; RATS, SPRAGUE-DAWLEY; REINFORCEMENT (PSYCHOLOGY); SELF ADMINISTRATION; SUCROSE;

RATTUS;

EID: 40849140472     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2008.02.002     Document Type: Article

References (29)

1. Ascher J.A., Cole J.O., Colin J.N., Feighner J.P., Ferris R.M., Fibiger H.C., et al. Bupropion: a review of its mechanism of antidepressant activity. J Clin Psychiatry 56 (1995) 395-401
2. Barr A.M., Panenka W.J., MacEwan W., Thornton A.E., Lang D.J., Honer W.G., et al. The need for speed: an update on methamphetamine addiction. J Psychiatry Neurosci 31 (2006) 301-313
3. Bruijnzeel A.W., and Markou A. Characterization of the effects of bupropion on the reinforcing properties of nicotine and food in rats. Synapse 50 (2003) 20-28
4. Dwoskin L.P., Rauhut A.S., King-Pospisil K.A., and Bardo M.T. Review of the pharmacology and clinical profile of bupropion, an antidepressant and tobacco use cessation agent. CNS Drug Rev 12 (2006) 178-207
5. Elkashef AM, Rawson RA, Anderson AL, Li S, Holmes T, Smith EV, et al. Bupropion for the treatment of methamphetamine dependence. Neuropsychopharmacology in press [Electronic publication ahead of print].
6. Gadde K.M., Parker C.B., Maner L.G., Wagner II H.R., Loque E.J., Drezner M.K., and Krishnan K.R. Bupropion for weight loss: an investigation of efficacy and tolerability in overweight and obese women. Obes Res 9 (2001) 544-551
7. Grabowski J., Shearer J., Merrill J., and Negus S. Agonist-like, replacement pharmacotherapy for stimulant abuse and dependence. Addict Behav 29 (2004) 1439-1464
8. Kim S., Westphalen R., Callahan B., Hatzidimitriou G., Yuan J., and Ricaurte G.A. Toward development of an in vitro model of methamphetamine-induced dopamine nerve terminal toxicity. J Pharmacol Exp Ther 293 (2000) 625-633
9. Ling W., Rawson R., and Shoptaw S. Management of methamphetamine abuse and dependence. Curr Psychiatry Rep 8 (2006) 345-354
10. Muley M.P., Joshi M.A., and Manekar M.S. Effect of bupropion on dopamine and 5-hydroxytryptamine-mediated behavior in mice. J Pharm Pharmacol 36 (1984) 208-210
11. Marek G.J., Vosmer G., and Seiden L.S. Dopamine uptake inhibitors block long-term neurotoxic effects of methamphetamine upon dopaminergic neurons. Brain Res 513 (1990) 274-279
12. Munzar P., and Goldberg S. Dopaminergic involvement in the discriminative-stimulus effects of methamphetamine in rats. Psychopharmacol 148 (2000) 209-217
13. NIDA Research Report Series. Methamphetamine abuse and addiction (2006) NIH Publication number 06-4210
14. National Research Council. Guide for the care and use of laboratory animals (1996), National Academy Press, Washington, DC
15. Newton T.F., Roach J.D., De La Garza II R., Fong T., Wallace C.L., Li S., et al. Safety of intravenous methamphetamine administration during treatment with bupropion. Psychopharmacology 182 (2005) 426-435
16. Newton T.F., Roach J.D., De La Garza II R., Fong T., Wallace C.L., Li S., et al. Bupropion reduces methamphetamine-induced subjective effects and cue-induced craving. Neuropsychopharmacology (2006) 1537-1544
17. Nomikos G.G., Damsma G., Wenkstern D., and Fibiger H.C. Effects of chronic bupropion on interstitial concentrations of dopamine in rat nucleus accumbens and striatum. Neuropsychopharmacology 7 (1992) 7-14
18. Panksepp J., Nocjar C., Burgdorf J., Panksepp J.B., and Huber R. The role of emotional systems in addiction: a neuroethological perspective. In: Bevins R.A., and Bardo M.T. (Eds). Nebraska symposium on motivation. Motivational factors in the etiology of drug abuse vol. 50 (2004), University of Nebraska Press, Lincoln, NE 85-126
19. Paterson N.E., Semenova S., Gasparini F., and Markou A. The mGluR5 antagonist MPEP decreases nicotine self-administration in rats and mice. Psychopharmacology 167 (2003) 257-264
20. Rauhut A.S., Neugebauer N., Dwoskin L.P., and Bardo M.T. Effect of bupropion on nicotine self-administration in rats. Psychopharmacology 169 (2003) 1-9
21. Reichel C.M., Wilkinson J.L., and Bevins R.A. Methamphetamine functions as a positive and negative drug feature in a Pavlovian appetitive discrimination task. Behav Pharmacol 18 (2007) 755-765
22. Roll J.M. Contigency management: an evidence-based component of methamphetamine use disorder treatments. Addiction 102 Suppl. 1 (2007) 114-120
23. Rothman R.B., Blough B.E., and Baumann M.H. Appetite suppressants as agonist substitution therapies for stimulant dependence. Ann N Y Acad Sci 965 (2002) 109-126
24. Sandoval V., Riddle E.L., Hanson G.R., and Fleckenstein A.E. Methylphenidate alters vesicular monoamine transport and prevents methamphetamine-induced dopamine deficits. J Pharmacol Exp Ther 304 (2003) 1181-1187
25. Substance Abuse and Mental Health Services Administration (SAMHSA). Results from the 2005 National Survey on Drug Use and Health (2006), DHHS, Rockville, MD NSDUH Series H-30. DHHS Pub No. SMA 06-4194
26. Sulzer D., Sonders M.S., Poulsen N.W., and Galli A. Mechanisms of neurotransmitter release by amphetamines: A review. Prog Neurobiol 75 (2005) 406-433
27. Suzuki T., Fukuoka Y., Mori T., Miyatake M., and Narita M. Behavioral sensitization to the discriminative stimulus effects of methamphetamine in rats. Eur J Pharmacol 498 (2004) 157-161
28. Vocci F.J., and Appel N.M. Approaches to the development of medications for the treatment of methamphetamine dependence. Addiction 102 Suppl. 1 (2007) 96-106
29. Zarrindast M.R., and Hosseini-Nia T. Anorectic and behavioural effects of bupropion. Gen Pharmacol 19 (1988) 201-204